TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 393 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,149,000 | -15.9% | 30,201 | -3.0% | 19.29% | +270.9% |
| Q4 2021 | $3,746,000 | +18.7% | 31,138 | +10.1% | 5.20% | +29.3% |
| Q3 2021 | $3,157,000 | +22.4% | 28,278 | +31.7% | 4.02% | +27.7% |
| Q2 2021 | $2,580,000 | +49.7% | 21,469 | +47.3% | 3.15% | +16.0% |
| Q1 2021 | $1,723,000 | +168.8% | 14,571 | -58.6% | 2.72% | +115.6% |
| Q4 2020 | $641,000 | +39.7% | 35,236 | +37.0% | 1.26% | +17.6% |
| Q3 2020 | $459,000 | -0.4% | 25,723 | 0.0% | 1.07% | +105.6% |
| Q2 2020 | $461,000 | -77.6% | 25,723 | -81.0% | 0.52% | -72.3% |
| Q1 2020 | $2,056,000 | -39.7% | 135,457 | -21.6% | 1.88% | -30.9% |
| Q4 2019 | $3,408,000 | +14.7% | 172,708 | 0.0% | 2.72% | -31.2% |
| Q3 2019 | $2,971,000 | -2.9% | 172,708 | -0.1% | 3.95% | +1.8% |
| Q2 2019 | $3,061,000 | -20.7% | 172,955 | -8.8% | 3.88% | -24.7% |
| Q1 2019 | $3,861,000 | – | 189,549 | – | 5.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |